Close Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,500
| Closed | -$23K | – | 227 |
|
|
2022
Q1 | $23K | Hold |
7,500
| – | – | ﹤0.01% | 159 |
|
|
2021
Q4 | $23K | Hold |
7,500
| – | – | ﹤0.01% | 159 |
|
|
2021
Q3 | $27K | Hold |
7,500
| – | – | ﹤0.01% | 154 |
|
|
2021
Q2 | $27K | Hold |
7,500
| – | – | ﹤0.01% | 145 |
|
|
2021
Q1 | $29K | Hold |
7,500
| – | – | ﹤0.01% | 150 |
|
|
2020
Q4 | $32K | Hold |
7,500
| – | – | ﹤0.01% | 101 |
|
|
2020
Q3 | $28K | Sell |
7,500
-3,000
| -29% | -$12.8K | ﹤0.01% | 107 |
|
|
2020
Q2 | $46K | Hold |
10,500
| – | – | ﹤0.01% | 108 |
|
|
2020
Q1 | $40K | Hold |
10,500
| – | – | ﹤0.01% | 114 |
|
|
2019
Q4 | $66K | Hold |
10,500
| – | – | 0.01% | 111 |
|
|
2019
Q3 | $44K | Hold |
10,500
| – | – | ﹤0.01% | 120 |
|
|
2019
Q2 | $49K | Sell |
10,500
-7,500
| -42% | -$34.9K | ﹤0.01% | 124 |
|
|
2019
Q1 | $95K | Buy |
18,000
+16,750
| +1,340% | +$76.5K | 0.01% | 112 |
|
|
2018
Q4 | $26K | Sell |
1,250
-16,750
| -93% | -$58.8K | ﹤0.01% | 135 |
|
|
2018
Q3 | $51K | Hold |
18,000
| – | – | ﹤0.01% | 131 |
|
|
2018
Q2 | $37K | Hold |
18,000
| – | – | ﹤0.01% | 136 |
|
|
2018
Q1 | $37K | Hold |
18,000
| – | – | ﹤0.01% | 142 |
|
|
2017
Q4 | $53K | Hold |
18,000
| – | – | ﹤0.01% | 125 |
|
|
2017
Q3 | $53K | Buy |
18,000
+6,500
| +57% | +$19.8K | 0.01% | 123 |
|
|
2017
Q2 | $31K | Buy |
+11,500
| New | +$24.3K | ﹤0.01% | 141 |
|
Close Asset Management's BDSI Position: Q2 2022 in Review
Close Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2022, closing a stake of 7,500 shares — an estimated $23K sold.
Close Asset Management first reported a position in BDSI in Q2 2017 and held it in 20 quarters. The position peaked at $95K in Q1 2019. 0 funds tracked by Wall St. Rank hold BDSI as of Q2 2022.
- Close Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2022 after selling out during the quarter.
- Close Asset Management sold 7,500 BioDelivery Sciences International, Inc. shares in Q2 2022, an estimated $23K.
- Close Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2017 and held it in 20 quarters.
- Close Asset Management's BioDelivery Sciences International, Inc. position peaked at $95K in Q1 2019.
- 0 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2022.
Based on Close Asset Management's 13F filing for Q2 2022, filed 29 Jul 2022.